Pearl River Capital, LLC Harmony Biosciences Holdings, Inc. Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$30.5 - $37.4 $47,031 - $57,670	-1,542 Reduced 16.82%	7,624 $268,000
Q1 2023 Dec 19, 2024	BUY	$30.8 - $53.92 $282,312 - $494,230	9,166 New	9,166 $299,000
Q1 2023 May 12, 2023	SELL	$30.8 - $53.92 $81,928 - $143,427	-2,660 Reduced 22.49%	9,166 $299,000
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $274,125 - $367,774	6,038 Added 104.32%	11,826 $651,000
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $4,921 - $6,487	117 Added 2.06%	5,788 $256,000
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $27,938 - $43,440	833 Added 17.22%	5,671 $277,000
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $160,331 - $247,366	4,838 New	4,838 $235,000

254

46.6M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.